4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-038789
Director sold 20,000 shares at an average $73.93 ($1,478,522)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-06-22 | Sale | −10,000 | $72.51 | $725,069 | 584,190 | I: show line 1 in the form |
| Bolzon Bradley J PhD Director | 2020-06-23 | Sale | −10,000 | $75.35 | $753,453 | 574,190 | I: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $73.93 · $1,478,522 | |||||||
Loading xslF345X03/doc4.xml…